ASH: Rituximab Dosing Schemes Prove Equal in Low-Burden FL MedPage Today Explain that maintenance therapy with rituximab (Rituxan) in low-burden follicular lymphoma provided disease control that was as good as rituximab retreatment at progression. Point out that grade 3-4 hematologic and nonhematologic toxicities occurred ... Re-treatment strategy challenges maintenance therapy for rituximab use in low ... |
